Understanding Biopharmaceutical Investment Decision Making: How Does CBO’s Model Compare to Investor Insights?

https://academic.oup.com/healthaffairsscholar/advance-article/doi/10.1093/haschl/qxaf200/8299842?rss=1&login=false